Founded in 2008, S1Biopharma is a clinical-stage biopharmaceutical company focused on the development and commercialization of drugs for the treatment of sexual dysfunction in both women and men. The company’s non-hormonal therapies work by restoring the natural balance of neurotransmitters in the brain.
Nicolas G. Sitchon - Chief Executive Officer
John F. Kaufmann - Chief Financial Officer
Robert E. Pyke - Medical Advisory Board Member, Previous Chief Medical Officer
Anita Clayton - Medical Advisory Board Member
and a representative from US Capital Global Securities will get in touch with you to provide more information on this investment opportunity.